Quick Answer
LISATA THERAPEUTICS, INC. reported Gross Profit of $1.72 million for fiscal year 2013.
LISATA THERAPEUTICS, INC. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2013 | $1.72M | -27.7% |
| 2012 | $2.38M | +69.6% |
| 2011 | $1.40M | -93.0% |
| 2010 | $20.15M | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2013 | $731.0K | +6.5% | +487.7% |
| June 30, 2013 | $124.4K | -80.4% | -5.6% |
| March 31, 2013 | $131.8K | -83.9% | -80.8% |
| September 30, 2012 | $686.5K | +140.3% | +7.9% |
| June 30, 2012 | $636.1K | +51.4% | -22.1% |
| March 31, 2012 | $817.0K | -84.6% | +186.0% |
| September 30, 2011 | $285.7K | -94.6% | -32.0% |
| June 30, 2011 | $420.1K | -93.5% | -92.1% |
- LISATA THERAPEUTICS, INC. showed a decrease of -27.7% in Gross Profit compared to the prior fiscal year.
- Over the 2010–2013 period, LISATA THERAPEUTICS, INC.’s gross profit has declined by 91.5% (from $20.15 million to $1.72 million).
- The most recent figure is from LISATA THERAPEUTICS, INC.’s fiscal year 2013 report (Form 10-K), filed with the SEC on March 13, 2014.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: